Amylin, Lilly Partnership Tested By Lilly GLP-1 Project
This article was originally published in The Pink Sheet Daily
Executive Summary
Byetta relationship is “the best it has ever been,” Amylin says, but impact of Lilly’s competitive research will need to be negotiated.
You may also be interested in...
Lilly, Amylin Expand Byetta Deal: Vote Of Confidence Or Down Payment?
Lilly pays $125 million upfront as part of supply agreement for long-acting Byetta formulation.
Lilly, Amylin Expand Byetta Deal: Vote Of Confidence Or Down Payment?
Lilly pays $125 million upfront as part of supply agreement for long-acting Byetta formulation.
“Unhappy” BMS To ImClone: Erbitux, Follow-on Still Ours
After the rejected buyout offer, rights to compounds won't be modified.